ArticleG3 (Bethesda, Md.)2025
Whole genome sequence of an edible mushroom Strobilomyces alpinus (Boletaceae).
Article in G3 (Bethesda, Md.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Genomic and Metabolomic Comparisons Provide New Insights into Plant Cell Wall Degradation, Mating Diversity and Secondary Metabolites in Brown and White CommercialInternational journal of molecular sciences · 2026Article
- Genomic insights and SSR marker development for trait improvement in Pleurotus giganteus for tropical cultivation.BMC plant biology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Strobilomyces alpinus is a unique and significant mushroom endemic to southwestern and central China, characterized by its exclusive subalpine distribution and a strong host preference for Abies spp. The biological and genetic studies of this mushroom are scarce, which significantly hinders research on molecular breeding and evolutionary patterns. In this study, we report the de novo sequencing and assembly of the S. alpinus genome using the DNBSEQ-T7 and the third-generation Pacific Biosciences sequencing platform. The total genome size was approximately 58.75 Mb, with a GC content of 54.87%. The genome assembly produced 68 contigs, with an N50 length of 4.03 Mb. The genome comprises 11,761 annotated protein-coding genes, including 813 CAZyme-coding genes, 182 Cytochrome P450 genes, and 1,821 candidate pathogenicity-related genes. The non-coding RNA prediction results indicated the presence of 532 rRNAs, 62 small RNAs, and 98 tRNAs in the S. alpinus genome. Notably, there is a high degree of repetition (44.28%) within the S. alpinus genome. Additionally, we identified 16 secondary metabolite gene clusters, including 7 NRPS-like clusters, 5 terpene clusters, 1 fungal-RiPP-like cluster, 1 RiPP-like cluster, 1 T1PKS cluster, and 1 T1PKS-NRPS linkage gene cluster. Several important metabolic pathways, including terpenoid backbone biosynthesis, porphyrin metabolism, and folate biosynthesis, have been elucidated. The annotated whole-genome sequence of S. alpinus can serve as a reference for investigations of bioactive compounds with medicinal value and for commercial production.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.